These restrictions on the BTNX NTS are remarkably pertinent, as we uncovered e.g. etodesnitazene to possess the same in vitro potency and efficacy as fentanyl [7, 13] and as it might probably give PWUD a false perception of protection. In addition, the detectability of nitazene analogues in drug samples might be impacted by solubility problems, as